Pascal M. Wielders

Eindhoven, NB, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate.

First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate.

Journal: The New England journal of medicine

Published: May 19, 2025

Identifying phenotypes in OSA patients with an indication for CPAP treatment using clinical data and experienced symptom severity.

Identifying phenotypes in OSA patients with an indication for CPAP treatment using clinical data and experienced symptom severity.

Journal: Journal of patient-reported outcomes

Published: April 16, 2024

Elderly patients with tuberculosis in a low-incidence country - Clinical characteristics, inflammation and outcome.

Elderly patients with tuberculosis in a low-incidence country - Clinical characteristics, inflammation and outcome.

Journal: The Journal of infection

Published: December 19, 2023

The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial.

The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial.

Journal: Respiratory research

Published: December 22, 2022

Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: A case series.

Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: A case series.

Journal: Med (New York, N.Y.)

Published: February 22, 2022

Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.

Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.

Journal: Therapeutic advances in respiratory disease

Published: October 21, 2020

Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease.

Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease.

Journal: International journal of chronic obstructive pulmonary disease

Published: July 23, 2019

Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD.

Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD.

Journal: Scientific reports

Published: November 23, 2018

ERS Congress highlight: educational forum on continuing professional development.

ERS Congress highlight: educational forum on continuing professional development.

Journal: Breathe (Sheffield, England)

Published: August 23, 2018

Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression.

Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression.

Journal: Respiratory research

Published: August 30, 2017

Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.

Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.

Journal: Drugs in R&D

Published: August 20, 2015

A new class of bronchodilator improves lung function in COPD: a trial with GSK961081.

A new class of bronchodilator improves lung function in COPD: a trial with GSK961081.

Journal: The European respiratory journal

Published: February 23, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026